Peptides in the Diagnosis and Treatment of Pancreatic Cancer and Other Pancreatic Diseases from Basic Research to Clinical Translation.

Drug Des Devel Ther · 2026 · PMC13285915 · PMID 42338763

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

124 Limitations The ASCEND trial employed a non-comparative randomized phase II design, and the primary endpoint did not reach statistical significance; the improvements in OS and OTRR represent exploratory signals.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.